Compare PFS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFS | BCRX |
|---|---|---|
| Founded | 1839 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2002 | 1995 |
| Metric | PFS | BCRX |
|---|---|---|
| Price | $22.10 | $9.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $23.75 | $20.82 |
| AVG Volume (30 Days) | 753.0K | ★ 4.6M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.28% | N/A |
| EPS Growth | 112.38 | ★ 381.40 |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $73,109,000.00 | $25,186,000.00 |
| Revenue This Year | $0.68 | N/A |
| Revenue Next Year | $5.97 | $12.55 |
| P/E Ratio | $36.21 | ★ N/A |
| Revenue Growth | ★ 7.06 | N/A |
| 52 Week Low | $15.92 | $6.00 |
| 52 Week High | $23.98 | $11.31 |
| Indicator | PFS | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.73 | 52.69 |
| Support Level | $21.53 | $8.89 |
| Resistance Level | $22.96 | $9.73 |
| Average True Range (ATR) | 0.41 | 0.43 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 61.60 | 56.43 |
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.